【Purpose】To examine the usefulness of Fresnel membrane prisms (Fresnel membranes) used in a trial before prescribing prism glasses for adults to improve double vision. 【Subjects and Method】Subjects were 105 patients (age, ≥ 20 years) who visited Nagoya University Hospital between January 1st, 2010 and December 31st, 2013 and complained of experiencing double vision. Of 105, 66 underwent a trial using Fresnel membranes before receiving prescribed prism glasses and 39 received prescribed glasses without a trial. By reviewing the medical records of these patients, we retrospectively investigated the duration of the Fresnel membrane trial, patientʼ s prescription type after the trial, frequency of prism power change of the Fresnel membranes during the trial, and use of the prism glasses three months after the prescription. 【Results】Of the 66 patients who had undergone the trial, 21 were prescribed with Fresnel prism glasses, 20 received built-in prism glasses, 4 had combined Fresnel and built-in prisms, 16 did not need prisms because their double vision was resolved, and 5 were not prescribed with any prisms because they could not adjust to the prisms. Among the subjects who underwent the trial for more than 1 month, 74% experienced prism power change of the Fresnel membranes for more than once. All the subjects who had undergone the trial could continue to wear their prescription prism glasses three months after the prescription. On the other hand, of the 39 patients who had not undergone the trial, 29 could continue to wear the prescription glasses, 3 had to change the prescription, and 7 discontinued. As compared to the subjects without the trial, a significantly higher number of the subjects who had experienced the trial Fresnel prisms could continue to wear their prescription glasses (P < 0.01). 【Conclusion】Before the prescription of prism glasses for adults with diplopia, a trial using the Fresnel membranes prisms appeared to be useful to determine the accurate type and power of the prism glasses and to help the patients continue to wear the prism glasses.
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